How to Read a Peptide Sequence UK: Amino Acid Notation Explained for Researchers (2026)

Daxer Labs

Oct 1

5 min read

Quick answer: reading a peptide sequence UK researchers rely on means recognising two parallel notation systems that should always agree with each other — the three-letter amino acid code (for example Gly-His-Lys) and the one-letter code (for example GHK) — and checking that both match exactly between a product listing, its Certificate of Analysis, and the published literature a researcher is citing before ordering.

Sequence notation looks simple once it is familiar, but it is also one of the easiest places for a mismatch to go unnoticed — a transposed letter, a missing modification, or a confused isomer can mean a researcher receives, cites, or orders a different compound to the one intended. This guide walks through both notation systems, works through a real research peptide sequence, and sets out what to check on a Certificate of Analysis before treating a sequence as confirmed.

Why Peptide Sequence Notation Matters for Research Buyers

A peptide's name — GHK-Cu, BPC-157, Ipamorelin — is a convenient shorthand, but the sequence is the actual definition of the compound: the specific order of amino acids joined by peptide bonds. Two products can share a similar-sounding name while differing in sequence length, amino acid substitution or salt form, and in UK research peptide listings, the sequence (or its notation) is often the only way to independently confirm that a product matches a specific paper a researcher intends to cite or replicate, rather than relying on the supplier's product description alone.

The Three-Letter Amino Acid Code Explained

The three-letter code is the more commonly seen format in supplier listings and Certificates of Analysis because it is easier to read at a glance. Each three-letter abbreviation represents one of the twenty standard amino acids. Examples relevant to commonly researched peptides include:

Gly — Glycine
His — Histidine
Lys — Lysine
Pro — Proline
Arg — Arginine
Leu — Leucine
Ser — Serine
Glu — Glutamic acid

A sequence written in three-letter code lists these abbreviations in order, separated by hyphens, from the N-terminus (the amino end) to the C-terminus (the acid end) of the peptide — for example, Gly-His-Lys for a three-amino-acid peptide.

The One-Letter Amino Acid Code Explained

The one-letter code compresses the same information into a single character per amino acid, which is the format most often used in scientific databases and journal articles because it keeps longer sequences readable. Using the same examples:

G — Glycine
H — Histidine
K — Lysine
P — Proline
R — Arginine
L — Leucine
S — Serine
E — Glutamic acid

Written in one-letter code, Gly-His-Lys becomes simply GHK. The two systems describe exactly the same sequence; a researcher should expect to see either, and occasionally both, depending on which document they are reading.

Reading a Real Research Peptide Sequence: GHK-Cu as a Worked Example

GHK-Cu is a useful worked example because its name states its sequence directly. The compound is a tripeptide — a chain of three amino acids — glycyl-L-histidyl-L-lysine, written in three-letter code as Gly-His-Lys and in one-letter code as GHK, bound to a copper(II) ion, hence the '-Cu' suffix. Reading the name this way, a researcher can confirm without a database lookup that the three letters correspond to glycine, histidine and lysine in that order, and that the compound is the copper complex of that tripeptide rather than the uncomplexed peptide alone — a distinction that matters because the copper-binding form is what most of the published research literature on this compound actually describes.

How Sequence Notation Appears on a Certificate of Analysis

A Certificate of Analysis that documents identity properly will typically state the sequence (in one or both notations), the molecular formula, the molecular weight, and the mass spectrometry result used to confirm that the received material matches that stated sequence, not just a product name. When the sequence isn't listed explicitly on a CoA, a researcher can still cross-check identity using the molecular weight, since even a single amino acid substitution changes it measurably, and comparing the CoA's stated molecular weight against the figure reported in the peptide's primary literature is a fast way to catch a mismatch before a study begins.

Common Sequence Notation Mistakes That Lead to Ordering the Wrong Compound

Confusing L- and D- amino acid isomers — nearly all research peptides use L-form amino acids, but a D-form substitution changes the compound's properties and is sometimes used deliberately to alter stability, so the isomer should be confirmed, not assumed.
Missing modification suffixes — acetate salt forms, amidated C-termini and other modifications are often appended to a sequence or name and change the compound's properties even when the core amino acid sequence is identical.
Case-sensitivity slips when reading one-letter code — a lower-case letter in some notation systems denotes a D-isomer rather than the standard L-isomer, so case is not purely stylistic.
Confusing peptide length homologs — compounds that share most of a sequence but differ by one or two amino acids at either end are sometimes marketed under very similar names, so the full sequence, not just the product name, is the safer identity check.

Sourcing Sequence-Verified Research Peptides in the UK

Because sequence notation is where the most easily missed mismatches occur, sourcing from a supplier that documents the full sequence and mass spectrometry confirmation on every batch-specific Certificate of Analysis removes most of the uncertainty. Daxer Labs' GHK-CU 100mg is supplied with a batch-specific Certificate of Analysis confirming identity by mass spectrometry, strictly for laboratory research use, so researchers can independently verify the sequence before a study begins rather than relying on the product name alone.

This article is provided for general laboratory reference information only. Daxer Labs supplies research peptides strictly for laboratory research use only — they are not intended for human or animal consumption, diagnostic or therapeutic use. Nothing in this article constitutes scientific, clinical or professional advice; sequence verification and identity-checking practices described here should be validated against your own laboratory's standards and, where applicable, institutional guidance.

Frequently Asked Questions

What is a peptide sequence?

A peptide sequence is the specific, ordered list of amino acids joined by peptide bonds that make up a peptide molecule, read from the N-terminus to the C-terminus, and written using either three-letter or one-letter amino acid abbreviations.

What is the difference between the one-letter and three-letter amino acid codes?

Both systems describe the same twenty standard amino acids; the three-letter code (such as Gly, His, Lys) is more readable at a glance and common on product listings and Certificates of Analysis, while the one-letter code (such as G, H, K) is more compact and typically used in scientific databases and longer published sequences.

How do you read the sequence GHK-Cu?

GHK-Cu reads as glycine-histidine-lysine (Gly-His-Lys in three-letter code, GHK in one-letter code), a tripeptide bound to a copper(II) ion, with the '-Cu' suffix indicating the copper complex rather than the uncomplexed peptide.

Why does the amino acid isomer (L- or D-) matter when reading a sequence?

Almost all standard research peptides use L-form amino acids; a D-form substitution changes the molecule's structure and properties, so confirming the isomer, rather than assuming the standard L-form, is part of verifying that a received compound matches its stated sequence.

Where should the sequence appear on a research peptide's Certificate of Analysis?

A thorough Certificate of Analysis lists the sequence alongside the molecular formula, molecular weight and mass spectrometry identity confirmation; if the sequence itself is not stated, the molecular weight can still be used to cross-check identity against the peptide's published literature.

Can two peptides with similar names have different sequences?

Yes. Compounds marketed under very similar names can differ by one or two amino acids, a modification suffix, or an isomer, which is why the full sequence, not the product name alone, is the more reliable way to confirm identity before ordering or citing a compound.